Company patents
Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. demonstrates a clear and intensifying focus on Medical Diagnostics & Surgery, which constitutes 76.4% of its portfolio and saw a remarkable 1100.0% growth in 2024, followed by a 50.0% increase in 2025, despite a partial decline of 38.9% so far in 2026. Surprisingly, the company also maintains a significant presence in Drug Delivery Devices (45.5% of portfolio), showing consistent patenting activity with 7 patents in both 2025 and so far in 2026, suggesting a dual-pronged strategy in medical device innovation.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
55 US filings (since 2023) · 4 categories · 3 themes
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Minimally invasive medical devices, typically flexible tubes, inserted into body lumens to deliver substances, remove obstructions, or perform localized treatments like ablation, dialysis, or drainage.
Focuses on the mechanical design, articulation, and actuation of hand-held or robotic surgical instruments, including improvements in stapling, cutting, grasping, and tissue manipulation.
Patents
Showing 1-10 of 78